\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ wbc\\ count\\.\\ \\ ua\\ had\\ rbc\\'s\\ but\\ inconclusive\\ because\\ patient\\ currently\\ menstruating\\.\\ right\\ cva\\ tenderness\\.\ \(0\)\
\-\ the\\ patient\\ was\\ treated\\ with\\ low\\-molecular\\-weight\\ heparin\\ \\ for\\ 5\\ days\\,\\ followed\\ by\\ warfarin\\ therapy\\ \\(target\\ inr\\ of\\ 2\\.0\\-3\\.0\\)\\ for\\ 6\\ months\\.\ \(0\)\
\-\ initial\\ non\\-con\\ stone\\ protocol\\ ct\\ exam\\:\\ there\\ was\\ no\\ renal\\ calculi\\,\\ hydronephrosis\\ or\\ further\\ renal\\ abnormality\\ present\\.\\ \\ on\\ the\\ images\\ through\\ the\\ lung\\ bases\\,\\ there\\ is\\ a\\ peripheral\\ wedge\\ shaped\\ opacity\\ in\\ the\\ right\\ lower\\ lobe\\ posterior\\ basal\\ segment\\.\\ \\ possibility\\ of\\ pulmonary\\ infarct\\ was\\ raised\\ by\\ the\\ radiologist\\,\\ ct\\ pulmonary\\ angiogram\\ was\\ recommended\\.\ \(0\)\
\-\ ct\\ pulmonary\\ angiogram\\:\\ \\ within\\ the\\ lul\\ and\\ the\\ lingular\\ segmental\\ pulmonary\\ arteries\\ are\\ filling\\ defects\\ consistent\\ with\\ pulmonary\\ emboli\\.\\ \\ additionally\\ in\\ a\\ subsegmental\\ branch\\ of\\ the\\ rll\\,\\ there\\ is\\ a\\ filling\\ defect\\ consistent\\ with\\ another\\ pulmonary\\ embolism\\.\\ \\ on\\ the\\ lung\\ windows\\,\\ distal\\ to\\ this\\ pe\\,\\ again\\ identified\\ is\\ a\\ wedge\\ shaped\\,\\ peripherally\\ based\\ opacity\\,\\ consistent\\ with\\ a\\ pulmonary\\ infarct\\.\ \(0\)\
\-\ pulmonary\\ embolism\\ with\\ rll\\ pulmonary\\ infarct\\.\ \(0\)\
\-\ after\\ the\\ ct\\ pe\\ protocol\\,\\ no\\ ddx\\.\ \(0\)\
\-\ 34\\ year\\ old\\ female\\ smoker\\,\\ on\\ ocps\\,\\ presents\\ to\\ the\\ er\\ with\\ right\\ flank\\ pain\\ and\\ remote\\ history\\ of\\ renal\\ stone\\ disease\\.\ \(0\)\
\-\ this\\ particular\\ case\\ was\\ interesting\\ because\\ the\\ patient\\ initially\\ presented\\ as\\ \\"renal\\ colic\\"\\,\\ however\\,\\ it\\ turned\\ out\\ that\\ her\\ flank\\ pain\\ was\\ coming\\ from\\ a\\ right\\ lower\\ lobe\\ pulmonary\\ infarction\\.\ \(0\)\
\-\ ct\\-pathologic\\ correlation\\ has\\ demonstrated\\ that\\ the\\ finding\\ of\\ wedge\\-shaped\\ opacity\\ at\\ ct\\ is\\ likely\\ to\\ represent\\ pulmonary\\ infarction\\,\\ that\\ is\\,\\ an\\ area\\ of\\ lung\\ filled\\ with\\ red\\ blood\\ cells\\ with\\ or\\ without\\ tissue\\ necrosis\\.\\ the\\ triangular\\ configuration\\ corresponds\\ to\\ increased\\ attenuation\\ within\\ several\\ affected\\ secondary\\ pulmonary\\ lobules\\,\\ with\\ a\\ broad\\ base\\ abutting\\ a\\ peripheral\\ pleural\\ surface\\ and\\ often\\ with\\ a\\ truncated\\ apex\\.\\ the\\ reported\\ prevalence\\ of\\ pulmonary\\ infarction\\ after\\ pe\\ has\\ been\\ estimated\\ to\\ be\\ 10\\%\\â\\€\\“15\\%\\ in\\ autopsy\\ series\\.\\ in\\ the\\ below\\ referenced\\ study\\,\\ they\\ showed\\ a\\ higher\\ prevalence\\ of\\ 25\\%\\ for\\ wedge\\-shaped\\ opacity\\ at\\ ct\\.\\ \\ this\\ may\\ reflect\\ differences\\ in\\ the\\ interval\\ between\\ the\\ embolic\\ event\\ and\\ the\\ ct\\ examination\\.\\ owing\\ to\\ subsequent\\ resolution\\ of\\ the\\ parenchymal\\ hemorrhage\\ associated\\ with\\ some\\ opacities\\,\\ a\\ greater\\ number\\ of\\ acute\\ pulmonary\\ infarcts\\ might\\ be\\ detected\\ on\\ ct\\ scans\\ than\\ in\\ autopsy\\ specimens\\.\ \(0\)\
\-\ reference\\:\ \(0\)\
\-\ a\\.\\ shah\\ et\\ al\\.\\,\\ \\ parenchymal\\ and\\ pleural\\ findings\\ in\\ patients\\ with\\ and\\ patients\\ without\\ acute\\ pulmonary\\ embolism\\ detected\\ at\\ spiral\\ ct\\;\\ \\ radiology\\.\\ 1999\\;211\\:147\\-153\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pulmonary\\:\\ 0\\.4518872123924186\ \(0\)\
\-\ wedge\\:\\ 0\\.206744162775938\ \(0\)\
\-\ the\\:\\ 0\\.19723500851602785\ \(0\)\
\-\ ct\\:\\ 0\\.1881593577909194\ \(0\)\
\-\ opacity\\:\\ 0\\.1720223918039424\ \(0\)\
\-\ shaped\\:\\ 0\\.16516643909475226\ \(0\)\
\-\ embolism\\:\\ 0\\.13441383789354888\ \(0\)\
\-\ infarct\\:\\ 0\\.12337972114511489\ \(0\)\
\-\ renal\\:\\ 0\\.12310928225974004\ \(0\)\
\-\ pe\\:\\ 0\\.12257493879877214\ \(0\)\
\-\ autopsy\\:\\ 0\\.12099378486667815\ \(0\)\
\-\ rll\\:\\ 0\\.11906643789572907\ \(0\)\
\-\ infarction\\:\\ 0\\.11639728373923648\ \(0\)\
\-\ with\\:\\ 0\\.11613253262061905\ \(0\)\
\-\ prevalence\\:\\ 0\\.10799229278061638\ \(0\)\
\-\ was\\:\\ 0\\.10334717396051091\ \(0\)\
\-\ of\\:\\ 0\\.0967193207460837\ \(0\)\
\-\ protocol\\:\\ 0\\.09646940902083154\ \(0\)\
\-\ detected\\:\\ 0\\.09481784923279855\ \(0\)\
\-\ stone\\:\\ 0\\.09028885206440242\ \(0\)\
\-\ lung\\:\\ 0\\.09019439669852654\ \(0\)\
\-\ angiogram\\:\\ 0\\.08879554234628786\ \(0\)\
\-\ parenchymal\\:\\ 0\\.08879554234628786\ \(0\)\
\-\ flank\\:\\ 0\\.0867016562537332\ \(0\)\
\-\ in\\:\\ 0\\.08606448943666191\ \(0\)\
\-\ consistent\\:\\ 0\\.08039543507759328\ \(0\)\
\-\ filling\\:\\ 0\\.07654766981557315\ \(0\)\
\-\ owing\\:\\ 0\\.0755257034021155\ \(0\)\
\-\ pleural\\:\\ 0\\.07441112599130563\ \(0\)\
\-\ to\\:\\ 0\\.0741344519934557\ \(0\)\
\-\ referenced\\:\\ 0\\.07303318820817292\ \(0\)\
\-\ menstruating\\:\\ 0\\.071099843223062\ \(0\)\
\-\ peripheral\\:\\ 0\\.07068361959846253\ \(0\)\
\-\ truncated\\:\\ 0\\.06952018535067803\ \(0\)\
\-\ because\\:\\ 0\\.06908295048495657\ \(0\)\
\-\ shah\\:\\ 0\\.0681846036498391\ \(0\)\
\-\ is\\:\\ 0\\.06767460956111238\ \(0\)\
\-\ ocps\\:\\ 0\\.06702767015673546\ \(0\)\
\-\ lobules\\:\\ 0\\.06702767015673546\ \(0\)\
\-\ right\\:\\ 0\\.06554355021780393\ \(0\)\
\-\ that\\:\\ 0\\.06434364957668358\ \(0\)\
\-\ subsegmental\\:\\ 0\\.06426854527760804\ \(0\)\
\-\ differences\\:\\ 0\\.06426854527760804\ \(0\)\
\-\ lingular\\:\\ 0\\.06351466729924056\ \(0\)\
\-\ inconclusive\\:\\ 0\\.06282116678549536\ \(0\)\
\-\ reflect\\:\\ 0\\.06282116678549536\ \(0\)\
\-\ lul\\:\\ 0\\.06217908559840163\ \(0\)\
\-\ coming\\:\\ 0\\.061581322314129626\ \(0\)\
\-\ and\\:\\ 0\\.06127638897971958\ \(0\)\
\-\ warfarin\\:\\ 0\\.060496892433339076\ \(0\)\
\-\ turned\\:\\ 0\\.060496892433339076\ \(0\)\
\-\ colic\\:\\ 0\\.06000166444174565\ \(0\)\
\-\ specimens\\:\\ 0\\.06000166444174565\ \(0\)\
\-\ on\\:\\ 0\\.059706807793843936\ \(0\)\
\-\ spiral\\:\\ 0\\.05908880712018707\ \(0\)\
\-\ there\\:\\ 0\\.05899620029331267\ \(0\)\
\-\ cva\\:\\ 0\\.05826302722617057\ \(0\)\
\-\ calculi\\:\\ 0\\.057877891327151695\ \(0\)\
\-\ abutting\\:\\ 0\\.057877891327151695\ \(0\)\
\-\ lobe\\:\\ 0\\.05712295495571914\ \(0\)\
\-\ at\\:\\ 0\\.056003482101607535\ \(0\)\
\-\ patients\\:\\ 0\\.055606681789561505\ \(0\)\
\-\ raised\\:\\ 0\\.05557580426269216\ \(0\)\
\-\ corresponds\\:\\ 0\\.05557580426269216\ \(0\)\
\-\ heparin\\:\\ 0\\.05399614639030819\ \(0\)\
\-\ windows\\:\\ 0\\.05352770089642707\ \(0\)\
\-\ acute\\:\\ 0\\.05347229242371495\ \(0\)\
\-\ embolic\\:\\ 0\\.053302645876562985\ \(0\)\
\-\ inr\\:\\ 0\\.05286934903579898\ \(0\)\
\-\ peripherally\\:\\ 0\\.05245669337480552\ \(0\)\
\-\ interesting\\:\\ 0\\.05225750917473311\ \(0\)\
\-\ without\\:\\ 0\\.05213792456783401\ \(0\)\
\-\ estimated\\:\\ 0\\.051324982988630335\ \(0\)\
\-\ target\\:\\ 0\\.051149944083638675\ \(0\)\
\-\ remote\\:\\ 0\\.051149944083638675\ \(0\)\
\-\ radiologist\\:\\ 0\\.0509783715244067\ \(0\)\
\-\ triangular\\:\\ 0\\.0509783715244067\ \(0\)\
\-\ this\\:\\ 0\\.050948265825037066\ \(0\)\
\-\ bases\\:\\ 0\\.05081013068262043\ \(0\)\
\-\ smoker\\:\\ 0\\.05064509462397067\ \(0\)\
\-\ lower\\:\\ 0\\.050510778155188944\ \(0\)\
\-\ might\\:\\ 0\\.05048314353281328\ \(0\)\
\-\ configuration\\:\\ 0\\.049864013699831615\ \(0\)\
\-\ rbc\\:\\ 0\\.04971590528794218\ \(0\)\
\-\ 1999\\:\\ 0\\.04971590528794218\ \(0\)\
\-\ correlation\\:\\ 0\\.04928619088721713\ \(0\)\
\-\ event\\:\\ 0\\.04928619088721713\ \(0\)\
\-\ emboli\\:\\ 0\\.04848585633046414\ \(0\)\
\-\ branch\\:\\ 0\\.04848585633046414\ \(0\)\
\-\ infarcts\\:\\ 0\\.048359370418219326\ \(0\)\
\-\ reference\\:\\ 0\\.048359370418219326\ \(0\)\
\-\ particular\\:\\ 0\\.04823470451041577\ \(0\)\
\-\ patient\\:\\ 0\\.048224810111634896\ \(0\)\
\-\ after\\:\\ 0\\.0479521606929118\ \(0\)\
\-\ ua\\:\\ 0\\.0471867552355663\ \(0\)\
\-\ opacities\\:\\ 0\\.0471867552355663\ \(0\)\
\-\ ddx\\:\\ 0\\.04697014067531838\ \(0\)\
\-\ segmental\\:\\ 0\\.04686383098436151\ \(0\)\
\-\ red\\:\\ 0\\.046552511345353216\ \(0\)\
\-\ apex\\:\\ 0\\.04645117532336805\ \(0\)\
\-\ possibility\\:\\ 0\\.0459615461242866\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.04586685522427677\ \(0\)\
\-\ within\\:\\ 0\\.04552574776730383\ \(0\)\
\-\ number\\:\\ 0\\.04549811314492816\ \(0\)\
\-\ series\\:\\ 0\\.04531946493719287\ \(0\)\
\-\ has\\:\\ 0\\.045150298186853566\ \(0\)\
\-\ for\\:\\ 0\\.0449395199809709\ \(0\)\
\-\ higher\\:\\ 0\\.044888324694102914\ \(0\)\
\-\ interval\\:\\ 0\\.044721701652920866\ \(0\)\
\-\ broad\\:\\ 0\\.0446395765725332\ \(0\)\
\-\ again\\:\\ 0\\.0440855164382294\ \(0\)\
\-\ 34\\:\\ 0\\.04307355226883302\ \(0\)\
\-\ scans\\:\\ 0\\.0430055979509856\ \(0\)\
\-\ defects\\:\\ 0\\.04260869812468656\ \(0\)\
\-\ basal\\:\\ 0\\.042291295191687235\ \(0\)\
\-\ by\\:\\ 0\\.041976047043075566\ \(0\)\
\-\ surface\\:\\ 0\\.041236247725188906\ \(0\)\
\-\ represent\\:\\ 0\\.0411265737150383\ \(0\)\
\-\ count\\:\\ 0\\.040805643280689814\ \(0\)\
\-\ segment\\:\\ 0\\.040805643280689814\ \(0\)\
\-\ additionally\\:\\ 0\\.04070125489611864\ \(0\)\
\-\ below\\:\\ 0\\.04070125489611864\ \(0\)\
\-\ affected\\:\\ 0\\.040649528586594326\ \(0\)\
\-\ another\\:\\ 0\\.040445657271930585\ \(0\)\
\-\ resolution\\:\\ 0\\.040100033567054855\ \(0\)\
\-\ be\\:\\ 0\\.0400981596456321\ \(0\)\
\-\ filled\\:\\ 0\\.03976766997828475\ \(0\)\
\-\ radiology\\:\\ 0\\.039583319808441216\ \(0\)\
\-\ recommended\\:\\ 0\\.0393139468857554\ \(0\)\
\-\ arteries\\:\\ 0\\.03922598540830584\ \(0\)\
\-\ initially\\:\\ 0\\.03875753991442472\ \(0\)\
\-\ et\\:\\ 0\\.038716183601483406\ \(0\)\
\-\ cells\\:\\ 0\\.038079998386791936\ \(0\)\
\-\ currently\\:\\ 0\\.0379657444527347\ \(0\)\
\-\ attenuation\\:\\ 0\\.03781571245946217\ \(0\)\
\-\ necrosis\\:\\ 0\\.037778606916193155\ \(0\)\
\-\ base\\:\\ 0\\.03759542607371636\ \(0\)\
\-\ subsequent\\:\\ 0\\.03741603806910484\ \(0\)\
\-\ er\\:\\ 0\\.0369663015678331\ \(0\)\
\-\ greater\\:\\ 0\\.036411346455708676\ \(0\)\
\-\ defect\\:\\ 0\\.03625466712078985\ \(0\)\
\-\ abnormality\\:\\ 0\\.03594956055563028\ \(0\)\
\-\ based\\:\\ 0\\.0358009440282605\ \(0\)\
\-\ reported\\:\\ 0\\.03559707271359675\ \(0\)\
\-\ pain\\:\\ 0\\.0353709914749898\ \(0\)\
\-\ they\\:\\ 0\\.035313905971212804\ \(0\)\
\-\ identified\\:\\ 0\\.03503970172211366\ \(0\)\
\-\ 25\\:\\ 0\\.03501275261450547\ \(0\)\
\-\ wbc\\:\\ 0\\.03493240460952364\ \(0\)\
\-\ or\\:\\ 0\\.03438701122868276\ \(0\)\
\-\ followed\\:\\ 0\\.03337499098841034\ \(0\)\
\-\ initial\\:\\ 0\\.033155077377723406\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.03309017721575419\ \(0\)\
\-\ study\\:\\ 0\\.03296181737009431\ \(0\)\
\-\ showed\\:\\ 0\\.03291944989637565\ \(0\)\
\-\ out\\:\\ 0\\.03248666848623797\ \(0\)\
\-\ finding\\:\\ 0\\.03248666848623797\ \(0\)\
\-\ several\\:\\ 0\\.03242657022600837\ \(0\)\
\-\ often\\:\\ 0\\.03224873689070356\ \(0\)\
\-\ further\\:\\ 0\\.032190261093182286\ \(0\)\
\-\ no\\:\\ 0\\.03214382620398853\ \(0\)\
\-\ between\\:\\ 0\\.03211290226577393\ \(0\)\
\-\ area\\:\\ 0\\.03201716503630074\ \(0\)\
\-\ examination\\:\\ 0\\.03162623566925538\ \(0\)\
\-\ days\\:\\ 0\\.03128712237175744\ \(0\)\
\-\ some\\:\\ 0\\.031096694242274413\ \(0\)\
\-\ tenderness\\:\\ 0\\.030994561848110665\ \(0\)\
\-\ her\\:\\ 0\\.03087690937531661\ \(0\)\
\-\ treated\\:\\ 0\\.03077732056493501\ \(0\)\
\-\ demonstrated\\:\\ 0\\.030374265050198853\ \(0\)\
\-\ likely\\:\\ 0\\.029534176100723907\ \(0\)\
\-\ through\\:\\ 0\\.029420546523051344\ \(0\)\
\-\ secondary\\:\\ 0\\.029294469633873322\ \(0\)\
\-\ however\\:\\ 0\\.02925284842759975\ \(0\)\
\-\ 10\\:\\ 0\\.028900268622831463\ \(0\)\
\-\ presented\\:\\ 0\\.028820901981338277\ \(0\)\
\-\ been\\:\\ 0\\.028794607177814877\ \(0\)\
\-\ months\\:\\ 0\\.028768391935089375\ \(0\)\
\-\ distal\\:\\ 0\\.028716198216339334\ \(0\)\
\-\ blood\\:\\ 0\\.02870319876737292\ \(0\)\
\-\ therapy\\:\\ 0\\.028396923657325913\ \(0\)\
\-\ than\\:\\ 0\\.028016695533243752\ \(0\)\
\-\ increased\\:\\ 0\\.026725800979451323\ \(0\)\
\-\ associated\\:\\ 0\\.026049815025050757\ \(0\)\
\-\ tissue\\:\\ 0\\.025926378740606288\ \(0\)\
\-\ posterior\\:\\ 0\\.02555724384593738\ \(0\)\
\-\ present\\:\\ 0\\.02536072935527919\ \(0\)\
\-\ it\\:\\ 0\\.02529912531943711\ \(0\)\
\-\ exam\\:\\ 0\\.024879742294270986\ \(0\)\
\-\ may\\:\\ 0\\.024871391323879142\ \(0\)\
\-\ case\\:\\ 0\\.024829756783834485\ \(0\)\
\-\ had\\:\\ 0\\.024624533283274783\ \(0\)\
\-\ but\\:\\ 0\\.02443992693356662\ \(0\)\
\-\ findings\\:\\ 0\\.02439240872792604\ \(0\)\
\-\ female\\:\\ 0\\.023849048981713104\ \(0\)\
\-\ presents\\:\\ 0\\.023775185524033803\ \(0\)\
\-\ images\\:\\ 0\\.02286159273869049\ \(0\)\
\-\ disease\\:\\ 0\\.020746169206938045\ \(0\)\
\-\ normal\\:\\ 0\\.020179224990307353\ \(0\)\
\-\ as\\:\\ 0\\.01985511628940069\ \(0\)\
\-\ from\\:\\ 0\\.01962886179960948\ \(0\)\
\-\ an\\:\\ 0\\.018899325557669756\ \(0\)\
\-\ history\\:\\ 0\\.018882583270120382\ \(0\)\
\-\ are\\:\\ 0\\.018753915964440995\ \(0\)\
\-\ year\\:\\ 0\\.015231305356610983\ \(0\)\
\-\ old\\:\\ 0\\.014627325589539816\ \(0\)\
